AtlaZ – Barbara Schoerg

"The AtlaZ platform facilitates rapid and straightforward early screenings in search of senescence-inducing drugs, particularly for anticancer therapies."

Barbara Schoerg; Postdoctoral researcher, Eberhard Karls University Tübingen
AtlaZ – Dr. Matthias Gossmann

"Due to the ease of use of the AtlaZ system, there was no support needed. After a brief introduction to the measurement software, we could start the experiments right away. Still, Nanion team was very supportive during the analysis and assessment of the recorded data."

Dr. Matthias Gossmann; co-founder and CEO at innoVitro
AtlaZ – Prof. Dr. Percy Knolle

"My experience with Nanion´s technology was great, achieving highly reproducible data with the AtlaZ platform from day 1 was convincing for me."

Prof. Dr. Percy Knolle, Technical University of Munich (TUM)

お問合せ先

本製品に関するご質問などございましたら、

いつでもお気軽にお問合せ下さい。